{
  "ptid_time": "109_S_1013_2006-11-08",
  "img_path": "/data/qiuhui/data/adni/images/109_S_1013/2006-11-08/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 38,478 mm³, 0.1% below the reference mean. With a Z-score of -0.00 (49.9th percentile), this represents normal volume ; hippocampal volume measures 7,144 mm³, 5.5% below the reference mean. With a Z-score of -0.54 (29.6th percentile), this represents normal volume ; whole brain volume measures 925,721 mm³, 14.2% below the reference mean. With a Z-score of -1.85 (3.2th percentile), this represents moderate atrophy; entorhinal cortex volume measures 3,871 mm³, 5.6% below the reference mean. With a Z-score of -0.38 (35.2th percentile), this represents normal volume ; fusiform gyrus volume measures 14,735 mm³, 21.8% below the reference mean. With a Z-score of -1.86 (3.2th percentile), this represents moderate atrophy; middle temporal gyrus volume measures 19,976 mm³, 6.4% below the reference mean. With a Z-score of -0.57 (28.3th percentile), this represents normal volume . ",
  "text_data": "Age is 77.8 years. Gender is Male. Education: 20 years. Handedness: Right. Race: Black or African American. Medical history: Neurologic; Head, Eyes, Ears, Nose and Throat; Dermatologic-Connective Tissue; Musculoskeletal; Renal-Genitourinary; Major Surgical Procedures. MMSE: 30.0. Logical Memory: 14.0. APOEε4 alleles: 0.0. Biomarker levels: Amyloid beta: 376.90 pg/mL (moderate reduced); Total tau: 109.70 pg/mL (moderate reduced); Phosphorylated tau: 10.89 pg/mL (mild reduced). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The patient shows moderate atrophy in whole brain and fusiform gyrus volumes, with otherwise normal hippocampal, entorhinal cortex, and middle temporal gyrus volumes. Biomarkers indicate moderately reduced Aβ (suggestive of amyloid pathology) but reduced tau levels (unusual for typical AD). Despite structural changes, cognitive performance (MMSE 30) remains intact.  \n**Diagnosis:** **CN (Cognitively Normal)**  \n**Confidence:** **Medium** (Biomarker and structural changes suggest early pathology, but preserved cognition and atypical tau levels complicate a definitive diagnosis at this stage.)",
  "timestamp": "2025-07-26T11:29:03.387429"
}